![]() |
Trials |
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158)Cancer type: Solide tumores Phase: II Principal Investigator: Guren Tormod Country: NO Keywords: Norway, Oslo, pemprolizumab Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02628067?term=KEYNOTE-158&rank=1 |